These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1144440)

  • 1. Interferon crosses blood-cerebrospinal fluid barrier in monkeys.
    Habif DV; Lipton R; Cantell K
    Proc Soc Exp Biol Med; 1975 May; 149(1):287-9. PubMed ID: 1144440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of human interferon-beta in monkeys.
    Hilfenhaus J; Damm H; Hofstaetter T; Mauler R; Ronneberger H; Weinmann E
    J Interferon Res; 1981; 1(3):427-36. PubMed ID: 6180075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
    Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
    Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rat fibroblast interferon.
    Abreu SL
    J Pharmacol Exp Ther; 1983 Jul; 226(1):197-200. PubMed ID: 6191024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte interferon administration to patients with symptomatic and suspected rabies.
    Merigan TC; Baer GM; Winkler WG; Bernard KW; Gibert CG; Chany C; Veronesi R
    Ann Neurol; 1984 Jul; 16(1):82-7. PubMed ID: 6205625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon administered in the cerebrospinal space and its effect on rabies in rabbits.
    Ho M; Nash C; Morgan CW; Armstrong JA; Carroll RG; Postic B
    Infect Immun; 1974 Feb; 9(2):286-93. PubMed ID: 4816460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes.
    Cantell K; Hirvonen S; Pyhälä L; De Reus A; Schellekens H
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1823-6. PubMed ID: 6409993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of interferon and viral antibodies in the cerebrospinal fluid in clinical neurology and psychiatry.
    Libíková H; Breier S; Kocisová M; Pogády J; Stünzner D; Ujházyová D
    Acta Biol Med Ger; 1979; 38(5-6):879-93. PubMed ID: 525159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
    Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
    Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon in cerebrospinal fluid. A marker for viral persistence of canine distemper encephalomyelitis.
    Tsai SC; Summers BA; Appel MJ
    Arch Virol; 1982; 72(4):257-65. PubMed ID: 6180708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders.
    Degré M; Dahl H; Vandvik B
    Acta Neurol Scand; 1976 Feb; 53(2):152-60. PubMed ID: 1266564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of human interferon to rabies virus-infected monkeys after exposure.
    Hilfenhaus J; Weinmann E; Majer M; Barth R; Jaeger O
    J Infect Dis; 1977 May; 135(5):846-9. PubMed ID: 404370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of interferon levels with leukocyte (2'-5') oligoadenylate synthetase activity as markers of viral encephalopathies.
    Kennedy CR; Tilles JG
    J Interferon Res; 1988 Oct; 8(5):609-15. PubMed ID: 2466911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain, blood-cerebrospinal fluid and cerebrospinal fluid-brain barriers in a marsupial (Macropus eugenii) during development.
    Dziegielewska KM; Hinds LA; Møllgård K; Reynolds ML; Saunders NR
    J Physiol; 1988 Sep; 403():367-88. PubMed ID: 3075668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How useful are serum and CSF interferon levels as a rapid diagnostic aid in virus infections?
    Flowers D; Scott GM
    J Med Virol; 1985 Jan; 15(1):35-47. PubMed ID: 2578554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF and serum interferon in multiple sclerosis: longitudinal study.
    Salonen R
    Neurology; 1983 Dec; 33(12):1604-6. PubMed ID: 6196687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.
    Mogensen KE; Pyhälä L; Törmä E; Cantell K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):305-10. PubMed ID: 4368958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.